Birth Control and Weight Gain: What Genetics and Research Really Show

Do birth control methods cause weight gain—and can your genes predict who will be affected? The answer depends on the method, the individual and the quality of the evidence. Some people notice weight changes after starting hormonal contraception, but gaining weight during use is not proof that the method caused it. The association is clearer for depot medroxyprogesterone acetate (DMPA) injections than for combined pills or the etonogestrel implant in population-level studies.

A 2020 exploratory study linked a variant in the ESR1 gene to greater measured weight gain among certain etonogestrel implant users. That finding is scientifically interesting, but it has not produced a validated genetic test for choosing birth control. This guide examines the original findings, subsequent research through November 2026, differences among contraceptives and sensible steps for discussing weight concerns with a clinician.

Does hormonal birth control actually cause weight gain?

Three questions often get conflated: Did someone gain weight after starting contraception? Did one contraceptive group gain more than another? And did the method cause the difference? Weight also changes with age, diet, physical activity, sleep, medication and medical conditions. Studies need appropriate comparison groups before a change can be attributed to a drug.

The UK National Health Service (NHS) lists weight gain among reported experiences with hormonal contraception, but notes that the evidence is often insufficient to establish causation. A Cochrane systematic review of progestin-only contraceptives found little difference in weight between comparison groups in many studies, while emphasizing the limitations of the underlying evidence.

What did the 2020 genetics study find?

Researchers at the University of Colorado analyzed records for 276 women using an etonogestrel contraceptive implant placed under the skin. They compared recorded weights around the time of implant placement and later enrollment, and examined 99 genetic variants for associations with weight change. The design was exploratory and retrospective; it was not a randomized trial capable of demonstrating that an implant caused the observed change.

• The median weight change was approximately +3.2 kg, and median implant-use duration was 27 months. A median is not the arithmetic mean and cannot be interpreted as an implant-attributable effect.
• Measured weight increased in about 73.9% of this specific sample. That is not the probability that an implant will cause weight gain in the general population.
• Participants with two copies of ESR1 rs9340799 had an average weight gain 14.1 kg greater than the comparison participants. It does not mean each carrier gained 14.1 kg.
• Self-reported and objectively recorded weight change agreed poorly, highlighting the value of consistent measurements rather than perceptions alone.

Original source: Lazorwitz and colleagues, Contraception (2020). The observations apply to etonogestrel implants in this study—not automatically to pills, injections, vaginal rings or intrauterine devices.

What is ESR1, and why might it matter?

The ESR1 gene encodes estrogen receptor alpha, a protein involved in responses to hormonal signals. Researchers proposed that genetic variation might contribute to differences in weight change during exposure to a progestin, but the precise mechanism remains unconfirmed. A statistical association alone cannot establish that a gene variant causes weight gain.

The widely quoted 14.1 kg figure is a difference between groups in a research sample, not a personal prediction. Independent replication and stronger comparisons would be necessary before such an association could inform routine clinical decisions. A 2025 pharmacogenetics review documents how preliminary the evidence remains.

What changed in the evidence in 2025 and 2026?

A genome-wide study of 900 implant users in 2025

A study published in February 2025 analyzed genes and circulating etonogestrel concentrations in 900 implant users. It found no common genetic variant reaching genome-wide statistical significance for variation in blood drug concentration, although exploratory analyses raised signals requiring more work. It measured drug concentration, not weight gain; it should not be treated as direct replication—or direct refutation—of the earlier ESR1 weight finding. Source: 2025 genome-wide association study.

A 2026 review revisited the evidence

A March 2026 narrative review summarized evidence across methods and highlighted how findings for DMPA differ from those for combined contraception and implants. However, it was a review, not a new clinical trial. Its discussion of ESR1 relies on the earlier exploratory work and does not establish that testing this gene improves counseling or predicts individual outcomes.

Birth control methods compared: what weight studies actually show

Evidence: Cochrane’s progestin-only review, its combined-contraceptive review and NHS injection guidance. There is no universal best method: pregnancy prevention, bleeding patterns, contraindications and individual preferences all matter.

Should you get a genetic test before choosing contraception?

No routine ESR1 genetic test is recommended for predicting implant-related weight gain. The finding is not sufficiently validated to identify who will gain weight or which method is medically preferable. Consumer DNA reports should not be used as a stand-alone reason to avoid, stop or switch an effective contraceptive method.

The CDC’s 2024 Selected Practice Recommendations explain that weighing someone or calculating BMI is not required to establish eligibility for an etonogestrel implant. However, documenting a baseline can be useful when someone is concerned about potential changes over time.

What to do if your weight changes after starting birth control

1. Establish a reliable baseline. If possible, use a pre-start or early-use measurement and weigh under similar conditions when checking trends.
2. Look at weeks and months, not daily fluctuations. Changes in body water, meals and menstrual cycles can temporarily alter the number on the scale.
3. Review other influences. Sleep, activity, diet, medications and medical conditions can all contribute. A clinician can decide whether symptoms warrant evaluation.
4. Discuss the complete trade-offs. Ask a qualified clinician about pregnancy-prevention effectiveness, bleeding patterns, medical history and alternatives.
5. Arrange another method before stopping. If you want an implant removed or contraception changed, plan the transition to avoid an unintended gap in protection.

Rapid or unexplained weight change accompanied by severe swelling, breathlessness or other concerning symptoms needs medical assessment rather than an assumption that birth control is responsible. You can also discuss changing methods when persistent side effects interfere with your wellbeing.

Does obesity make an implant unsuitable or ineffective?

The CDC 2024 Medical Eligibility Criteria do not classify obesity alone as a reason to avoid an etonogestrel implant. Method eligibility must still consider the full medical history and other relevant circumstances. The implant is highly effective contraception, but it does not protect against sexually transmitted infections; appropriate barrier protection remains important where there is exposure risk.

Weight, body fat and fluid retention are not the same thing

A stable body weight may coexist with changes in fat and lean tissue, while a short-term rise may largely reflect water. Studies vary in what they measure and how they control for confounding. There is no single number for expected weight change that is scientifically valid for every contraceptive method and every person.

Frequently asked questions

Does an etonogestrel implant cause a 3.2 kg gain in everyone?

No. The 3.2 kg figure is the median observed weight change in one research sample over a median of 27 months. It is not the implant’s proven causal effect or a personal prediction.

Will having ESR1 rs9340799 make me gain 14 kg?

Not necessarily. The study reported a group difference, not a guaranteed amount for every carrier. The result has not become a clinically validated genetic screening tool.

Which has stronger evidence of weight gain: the implant or DMPA injections?

The evidence of an association is clearer for DMPA injections among some users. Evidence for a large, consistent implant-caused weight increase in the general population is weaker.

Do combined oral contraceptives cause obesity?

A Cochrane review found no consistent evidence of a large causal weight effect in trials of combined contraception. Personal experiences still deserve attention and a discussion of options with a qualified clinician.

Can I have my implant removed because of weight concerns?

You can discuss removal with a qualified clinician if it no longer meets your needs. Arrange effective alternative contraception if pregnancy is not desired.

Can an at-home DNA test tell me which birth control method will affect my weight?

No validated, routine genetic test can currently make a reliable individual prediction of weight change across contraceptive methods.

The bottom line

Birth control and weight should not be reduced to a universal claim. The 2020 ESR1 study was an intriguing hypothesis-generating finding, not proof of causation or a usable screening test. Research on contraception shows meaningful differences between methods, especially for DMPA injections. Keep track of persistent changes, evaluate other possible explanations and make contraceptive decisions together with a qualified clinician.

Original studies and clinical guidance

• Lazorwitz et al., Contraception (2020): original etonogestrel implant genetics study.
• Lazorwitz et al., O&G Open (2025): genome-wide study of drug concentrations in 900 implant users.
• Contraceptive-Induced Weight Gain—Myth and Reality Review (2026).
• Cochrane systematic review: progestin-only contraception and weight.
• Cochrane systematic review: combined contraception and weight.
• CDC U.S. Selected Practice Recommendations for Contraceptive Use (2024).
• NHS: contraceptive implant side effects and risks.
• NHS: contraceptive injection side effects and risks.